missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CTRP3/C1qTNF3/CORS26 Antibody, R&D Systems™

Sheep Polyclonal Antibody
Brand: R&D Systems AF7925-SP
This item is not returnable.
View return policy
Description
C1qTNF3/CORS26/CTRP3 Polyclonal specifically detects C1qTNF3/CORS26/CTRP3 in Human samples. It is validated for Western Blot, Immunocytochemistry.
Specifications
| C1qTNF3/CORS26/CTRP3 | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| C1ATNF3, C1q and tumor necrosis factor related protein 3, C1qTNF3, Cartducin, cartonectin, collagenous repeat-containing sequence of 26-kDa, complement C1q tumor necrosis factor-related protein 3, complement-c1q tumor necrosis factor-related protein 3, Corcs, Cors, Cors-26, CORS26, CTRP32310005P21Rik, FLJ37576, Secretory protein CORS26 | |
| Sheep | |
| Affinity Purified | |
| RUO | |
| 114899 | |
| Sterile PBS to a final concentration of 0.2 mg/mL. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
| Western Blot, Immunocytochemistry | |
| LYOPH | |
| Western Blot 1 ug/mL, Immunocytochemistry 5-15 ug/mL | |
| Q9BXJ4 | |
| C1QTNF3 | |
| Mouse myeloma cell line NS0-derived recombinant human CTRP3/C1qTNF3/CORS26 Asp24-Lys246 Accession # Q9BXJ4 | |
| 25 μg | |
| Primary | |
| Detects human CTRP3/C1qTNF3/CORS26 in direct ELISAs and Western blots. In direct ELISAs, approximately 40% cross-reactivity with recombinant mouse CTRP3/C1qTNF3/CORS26 is observed. | |
| Human | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction